Medicina
Département
University of Groningen
Groninga, HolandaPublications en collaboration avec des chercheurs de University of Groningen (167)
2024
-
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
eClinicalMedicine, Vol. 71
-
Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries
The Lancet Regional Health - Europe, Vol. 38
-
Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study
Future oncology (London, England), Vol. 20, Núm. 6, pp. 297-306
2023
-
A deep learning system for detection of early Barrett's neoplasia: a model development and validation study
The Lancet Digital Health, Vol. 5, Núm. 12, pp. e905-e916
-
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
Nature Medicine, Vol. 29, Núm. 7, pp. 1867-1876
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD
Journal of the American Society of Nephrology : JASN, Vol. 34, Núm. 6, pp. 955-968
-
Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies
Rheumatology (United Kingdom), Vol. 62, Núm. 1, pp. 243-255
-
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
New England Journal of Medicine, Vol. 389, Núm. 4, pp. 335-347
-
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
The Lancet, Vol. 402, Núm. 10417, pp. 2077-2090
-
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD
Clinical journal of the American Society of Nephrology : CJASN, Vol. 18, Núm. 2, pp. 183-192
-
Humoral response after the fourth dose of the SARS-CoV-2 vaccine in the CKD spectrum: a prespecified analysis of the SENCOVAC study
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 4, pp. 969-981
-
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
Blood Advances, Vol. 7, Núm. 11, pp. 2645-2655
-
Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission
British Journal of Haematology, Vol. 201, Núm. 6, pp. 1169-1178
-
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
eClinicalMedicine, Vol. 58
-
Nutritional status and the risk of malnutrition in older adults with chronic kidney disease – implications for low protein intake and nutritional care: A critical review endorsed by ERN-ERA and ESPEN
Clinical Nutrition, Vol. 42, Núm. 4, pp. 443-457
-
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY
eClinicalMedicine, Vol. 65
-
Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma
Cancer Medicine, Vol. 12, Núm. 11, pp. 12071-12083
-
Practical guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline
Clinical Nutrition, Vol. 42, Núm. 6, pp. 987-1024
-
Prediction of Nonrelapse Mortality in Patients with Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation with Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis
HemaSphere